CA2290506C
(en)
|
1997-07-01 |
2005-12-27 |
Warner-Lambert Company |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
|
US5932580A
(en)
|
1997-12-01 |
1999-08-03 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds their preparation and compositions
|
IL139080A0
(en)
|
1998-04-17 |
2001-11-25 |
Parker Hughes Inst |
Btx inhibitors and methods for their indentification and use
|
HUP0102563A3
(en)
|
1998-05-04 |
2003-04-28 |
Zentaris Gmbh |
Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
|
NZ513433A
(en)
|
1999-01-13 |
2003-05-30 |
Warner Lambert Co |
Benzoheterocycles, their use as MEK inhibitors and use in treating proliferative diseases such as cancer
|
ATE311363T1
(de)
|
1999-01-13 |
2005-12-15 |
Warner Lambert Co |
Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
BR9916885A
(pt)
|
1999-01-13 |
2001-11-20 |
Warner Lambert Co |
Derivados de benzeno-sulfonamida e seu uso comoinibidores da mek
|
WO2000056706A1
(en)
|
1999-03-19 |
2000-09-28 |
Du Pont Pharmaceuticals Company |
Amino-thio-acrylonitriles as mek inhibitors
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
ES2237430T3
(es)
|
1999-06-09 |
2005-08-01 |
Yamanouchi Pharmaceutical Co. Ltd. |
Nuevos derivados carboxamida heterociclicos.
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
WO2001025238A2
(en)
|
1999-10-06 |
2001-04-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
EP1263759B1
(en)
|
1999-12-24 |
2010-09-08 |
Aventis Pharma Limited |
Azaindoles
|
DE60129926T2
(de)
|
2000-01-24 |
2008-06-19 |
Genzyme Corp., Cambridge |
Inhibitoren des jak/stat-weges und deren verwendung zur behandlung von allgemeiner primärer osteoarthritis
|
AU3977001A
(en)
|
2000-02-15 |
2001-08-27 |
Sugen Inc |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
US7087608B2
(en)
|
2000-03-03 |
2006-08-08 |
Robert Charles Atkins |
Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
|
JP2003527379A
(ja)
|
2000-03-15 |
2003-09-16 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Mex阻害物質としての5−アミド置換ジアリールアミン類
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
DE10017480A1
(de)
|
2000-04-07 |
2001-10-11 |
Transmit Technologietransfer |
Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
WO2002069960A2
(en)
|
2001-03-06 |
2002-09-12 |
Axxima Pharmaceuticals Ag |
Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock
|
ATE427948T1
(de)
|
2001-04-24 |
2009-04-15 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
EP1401412A2
(en)
|
2001-06-29 |
2004-03-31 |
AB Science |
Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
|
WO2003002114A2
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
|
WO2003003006A2
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
New potent, selective and non toxic c-kit inhibitors
|
EP1450775B1
(en)
|
2001-09-20 |
2008-03-12 |
AB Science |
C-kit inhibitors for treating bacterial infections
|
EP1430053B1
(en)
|
2001-09-27 |
2006-10-25 |
SmithKline Beecham Corporation |
AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
ES2335276T3
(es)
|
2002-03-13 |
2010-03-24 |
Array Biopharma, Inc. |
Derivados de bencimidazol alquilado n3 como inhibidores de mek.
|
WO2003077855A2
(en)
|
2002-03-13 |
2003-09-25 |
Array Biopharma, Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
EP1487424B1
(en)
|
2002-03-15 |
2006-09-13 |
Novartis AG |
4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
|
DE60335099D1
(de)
|
2002-05-06 |
2011-01-05 |
Vertex Pharma |
Thiadiazole oder oxadiazole und ihre verwendung als jak proteinkinaseinhibitoren
|
KR20050013562A
(ko)
|
2002-05-30 |
2005-02-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Jak 및 cdk2 프로테인 키나아제의 억제제
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
WO2004011461A1
(en)
|
2002-07-25 |
2004-02-05 |
Pfizer Products Inc. |
Isothiazole derivatives useful as anticancer agents
|
NZ538490A
(en)
|
2002-08-02 |
2006-12-22 |
Ab Science |
2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-kit inhibitors
|
US7312227B2
(en)
|
2002-11-01 |
2007-12-25 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
WO2004041814A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
AU2003286895A1
(en)
|
2002-11-05 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
WO2004080462A1
(ja)
|
2003-03-10 |
2004-09-23 |
Eisai Co., Ltd. |
c-Kitキナーゼ阻害剤
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
EP1648455A4
(en)
|
2003-07-23 |
2009-03-04 |
Exelixis Inc |
MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE
|
WO2005018677A2
(en)
|
2003-08-01 |
2005-03-03 |
Wyeth Holdings Corporation |
Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
|
WO2005016894A1
(en)
|
2003-08-15 |
2005-02-24 |
Novartis Ag |
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
|
DE602004017623D1
(de)
|
2003-08-21 |
2008-12-18 |
Osi Pharm Inc |
N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitoren
|
CN1839132A
(zh)
|
2003-08-21 |
2006-09-27 |
Osi制药公司 |
作为c-kit抑制剂的n3-取代的咪唑并吡啶衍生物
|
UA82395C2
(en)
|
2003-08-21 |
2008-04-10 |
Оси Фармасьютикалз, Инк. |
N-substituted benzimidazolyl c-kit inhibitors
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
DE10342794A1
(de)
|
2003-09-16 |
2005-04-21 |
Basf Ag |
Sekretion von Proteinen aus Hefen
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
TW200520745A
(en)
|
2003-09-19 |
2005-07-01 |
Chugai Pharmaceutical Co Ltd |
Novel 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
|
KR20060097000A
(ko)
|
2003-09-23 |
2006-09-13 |
노파르티스 아게 |
화학요법제와 vegf 수용체 저해제의 배합물
|
RU2405784C2
(ru)
|
2003-10-15 |
2010-12-10 |
Оси Фармасьютикалз, Инк. |
Имидазопиразины в качестве ингибиторов тирозинкиназ
|
US7476729B2
(en)
|
2003-10-24 |
2009-01-13 |
Institut Curie |
Dbait and uses thereof
|
EP1526177A1
(en)
|
2003-10-24 |
2005-04-27 |
Institut Curie |
Nucleic acids useful for triggering tumor cell lethality
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
MXPA06005657A
(es)
|
2003-11-19 |
2006-08-23 |
Array Biopharma Inc |
Inhibidores heterociclicos de mek y metodos para usarlos.
|
DE102004001607A1
(de)
|
2004-01-09 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
|
EP1711497A1
(en)
|
2004-01-30 |
2006-10-18 |
AB Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
TW200538097A
(en)
|
2004-02-27 |
2005-12-01 |
Eisai Co Ltd |
Novel pyridine derivative and pyrimidine derivative
|
EP1730146B1
(en)
|
2004-03-30 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of jak and other protein kinases
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
UA89493C2
(uk)
|
2004-04-02 |
2010-02-10 |
Оси Фармасьютикалз, Инк. |
6,6-біциклічні кільцеві заміщені гетеробіциклічні інгібітори протеїнкіназ
|
US20080275022A1
(en)
|
2004-06-15 |
2008-11-06 |
Astrazeneca Ab |
Substituted Quinazolones as Anti-Cancer Agents
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
CN103251953A
(zh)
|
2004-07-19 |
2013-08-21 |
约翰·霍普金斯大学 |
供免疫抑制的flt3抑制剂
|
TWI361066B
(en)
|
2004-07-26 |
2012-04-01 |
Chugai Pharmaceutical Co Ltd |
5-substituted-2-phenylamino benzamides as mek inhibitors
|
WO2007040469A2
(en)
|
2005-09-15 |
2007-04-12 |
Kosak Ken M |
Chloroquine coupled compositions and methods for their synthesis
|
US20090118261A1
(en)
|
2004-08-31 |
2009-05-07 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
JP2008511600A
(ja)
|
2004-09-01 |
2008-04-17 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体およびB−Raf抑制剤としてそれらの使用
|
KR20070057955A
(ko)
|
2004-09-17 |
2007-06-07 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제로서 유용한 디아미노트리아졸 화합물
|
US20080207616A1
(en)
|
2004-10-15 |
2008-08-28 |
Astrazeneca Ab |
Quinoxalines as B Baf Inhhibitors
|
EP1838675A1
(en)
|
2004-11-24 |
2007-10-03 |
Laboratoires Serono S.A. |
Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
|
RU2007123675A
(ru)
|
2004-11-24 |
2008-12-27 |
Новартис АГ (CH) |
Комбинации ингибиторов jak
|
ES2330872T3
(es)
|
2004-12-01 |
2009-12-16 |
Merck Serono Sa |
Derivados de (1,2,4)triazolo(4,3-a)piridina para el tratamiento de enfermedades hiperproliferativas.
|
EP1831206B1
(en)
|
2004-12-01 |
2011-08-24 |
OSI Pharmaceuticals, Inc. |
N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
ATE427946T1
(de)
|
2004-12-22 |
2009-04-15 |
Astrazeneca Ab |
Pyridincarbonsaureamidderivate zur verwendung als antikrebsmittel
|
WO2006079791A1
(en)
|
2005-01-25 |
2006-08-03 |
Astrazeneca Ab |
Chemical compounds
|
AU2006209712B2
(en)
|
2005-01-27 |
2011-06-09 |
Kyowa Hakko Kirin Co., Ltd. |
IGF-1R inhibitor
|
DK1846394T3
(da)
|
2005-02-04 |
2012-01-16 |
Astrazeneca Ab |
Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer
|
DK1853602T3
(da)
|
2005-02-16 |
2010-09-20 |
Astrazeneca Ab |
Kemiske forbindelser
|
DK1853588T3
(da)
|
2005-02-16 |
2008-09-15 |
Astrazeneca Ab |
Kemiske forbindelser
|
EP1854793A4
(en)
|
2005-02-28 |
2011-01-26 |
Japan Tobacco Inc |
NEW AMINOPYRIDEIN COMPOUND WITH SYK-HEMDERING EFFECT
|
AU2006229343A1
(en)
|
2005-03-28 |
2006-10-05 |
Kirin Pharma Kabushiki Kaisha |
Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
|
US20080242704A1
(en)
|
2005-04-04 |
2008-10-02 |
Ab Science |
Substituted Oxazole Derivatives and their Use as Tyrosine Kinase Inhibitors
|
CA2610446A1
(en)
|
2005-04-19 |
2006-10-26 |
Kyowa Hakko Kogyo Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
US20080287437A1
(en)
|
2005-05-16 |
2008-11-20 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
|
CN101626767A
(zh)
|
2005-05-18 |
2010-01-13 |
阵列生物制药公司 |
Mek的杂环抑制剂及其使用方法
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
WO2006133417A1
(en)
|
2005-06-07 |
2006-12-14 |
Valeant Pharmaceuticals International |
Phenylamino isothiazole carboxamidines as mek inhibitors
|
US20070021435A1
(en)
|
2005-06-10 |
2007-01-25 |
Gaul Michael D |
Aminopyrimidines as kinase modulators
|
TW200738638A
(en)
|
2005-06-23 |
2007-10-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
JP4119478B1
(ja)
|
2005-06-23 |
2008-07-16 |
メルク エンド カムパニー インコーポレーテッド |
チロシンキナーゼインヒビター
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
JP5071374B2
(ja)
|
2005-07-14 |
2012-11-14 |
アステラス製薬株式会社 |
ヘテロ環ヤヌスキナーゼ3阻害剤
|
EP1904065A2
(en)
|
2005-07-14 |
2008-04-02 |
AB Science |
Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
|
WO2007028445A1
(en)
|
2005-07-15 |
2007-03-15 |
Glaxo Group Limited |
6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
|
AR054834A1
(es)
|
2005-07-15 |
2007-07-18 |
Glaxo Group Ltd |
Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diamina
|
PT1912636E
(pt)
|
2005-07-21 |
2014-07-24 |
Ardea Biosciences Inc |
Inibidores de n-(arilamino)-sulfonamida de mek
|
CN101198590B
(zh)
|
2005-08-24 |
2012-05-09 |
卫材R&D管理有限公司 |
吡啶衍生物及嘧啶衍生物(3)
|
CA2621503C
(en)
|
2005-09-07 |
2014-05-20 |
Rigel Pharmaceuticals, Inc. |
Triazole derivatives useful as axl inhibitors
|
NZ566862A
(en)
|
2005-09-27 |
2010-12-24 |
Irm Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of C-kit receptors
|
FR2891273B1
(fr)
|
2005-09-27 |
2007-11-23 |
Aventis Pharma Sa |
NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
|
CN109053523B
(zh)
|
2005-10-07 |
2022-03-25 |
埃克塞利希斯股份有限公司 |
作为用于治疗增生性疾病的mek抑制剂的吖丁啶
|
EP1948658A1
(en)
|
2005-10-13 |
2008-07-30 |
Glaxo Group Limited |
Pyrrolopyrimidine derivatives as syk inhibitors
|
CA2632283C
(en)
|
2005-12-05 |
2011-06-21 |
Pfizer Products Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
ES2612196T3
(es)
|
2005-12-13 |
2017-05-12 |
Incyte Holdings Corporation |
Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus
|
WO2007075554A2
(en)
|
2005-12-19 |
2007-07-05 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
EP1966155A1
(en)
|
2005-12-21 |
2008-09-10 |
AstraZeneca AB |
Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
|
US20080306096A1
(en)
|
2005-12-22 |
2008-12-11 |
Astrazeneca Ab |
Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
|
CA2636189A1
(en)
|
2006-01-17 |
2007-07-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of janus kinases
|
FR2896503B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
GB0601962D0
(en)
|
2006-01-31 |
2006-03-15 |
Ucb Sa |
Therapeutic agents
|
TW200740776A
(en)
|
2006-02-06 |
2007-11-01 |
Osi Pharm Inc |
N-phenylbenzotriazolyl c-kit inhibitors
|
MX2008012096A
(es)
|
2006-03-22 |
2008-12-17 |
Vertex Pharma |
Inhibidores de proteina cinasa c-met para el tratamiento de trastornos proliferativos.
|
WO2007113557A1
(en)
|
2006-04-05 |
2007-10-11 |
Astrazeneca Ab |
Substituted quinazolines with anti-cancer activity
|
JP2009532450A
(ja)
|
2006-04-05 |
2009-09-10 |
アストラゼネカ アクチボラグ |
化合物
|
EP2001884A1
(en)
|
2006-04-05 |
2008-12-17 |
Vertex Pharmaceuticals, Inc. |
Deazapurines useful as inhibitors of janus kinases
|
US20090203718A1
(en)
|
2006-04-13 |
2009-08-13 |
Smithkline Beecham (Cork) Ltd. |
Cancer treatment method
|
JP2009534364A
(ja)
|
2006-04-18 |
2009-09-24 |
アストラゼネカ アクチボラグ |
キナゾリン−4−オン誘導体、それらの製造方法およびそれらを含有する医薬組成物
|
ATE483463T1
(de)
|
2006-04-18 |
2010-10-15 |
Ardea Biosciences Inc |
Pyridonsulfonamide und pyridonsulfamide als mek- hemmer
|
KR20090005195A
(ko)
|
2006-04-19 |
2009-01-12 |
라보라뚜와르 세로노 에스. 에이. |
Mek 저해제로서 신규한 헤테로아릴-치환된 아릴아미노피리딘 유도체
|
US8163746B2
(en)
|
2006-04-19 |
2012-04-24 |
Astellas Pharma Inc. |
Azolecarboxamide derivative
|
EA016611B1
(ru)
|
2006-04-20 |
2012-06-29 |
Янссен Фармацевтика Н.В. |
Способ лечения мастоцитоза
|
US20090306214A1
(en)
|
2006-05-09 |
2009-12-10 |
Eliahu Kaplan |
Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders
|
CA2652442C
(en)
|
2006-05-18 |
2014-12-09 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
WO2008005877A2
(en)
|
2006-06-30 |
2008-01-10 |
Board Of Regents, The University Of Texas System |
Inhibitors of c-kit and uses thereof
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
WO2008011080A2
(en)
|
2006-07-20 |
2008-01-24 |
Amgen Inc. |
Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine
|
KR20090047509A
(ko)
|
2006-08-04 |
2009-05-12 |
다케다 야쿠힌 고교 가부시키가이샤 |
융합 헤테로시클릭 유도체 및 이의 용도
|
US20100216791A1
(en)
|
2006-08-17 |
2010-08-26 |
Astrazeneca |
Pyridinylquinazolinamine derivatives and their use as b-raf inhibitors
|
KR101133799B1
(ko)
|
2006-08-18 |
2012-04-24 |
에프. 호프만-라 로슈 아게 |
폴리뉴클레오타이드의 생체내 전달을 위한 다가접합체
|
ATE535520T1
(de)
|
2006-08-23 |
2011-12-15 |
Eisai R&D Man Co Ltd |
Salz eines phenoxypyridinderivats oder kristall davon und verfahren zu dessen herstellung
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
SI2526933T1
(sl)
|
2006-09-22 |
2015-07-31 |
Pharmacyclics, Inc. |
Inhibitorji Bruton tirozin kinaze
|
WO2008045978A1
(en)
|
2006-10-10 |
2008-04-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
|
CN101558068A
(zh)
|
2006-10-16 |
2009-10-14 |
诺瓦提斯公司 |
用作蛋白激酶抑制剂的苯乙酰胺类
|
JPWO2008047831A1
(ja)
|
2006-10-17 |
2010-02-25 |
協和発酵キリン株式会社 |
Jak阻害剤
|
TW200829566A
(en)
|
2006-12-08 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
AU2007334402B2
(en)
|
2006-12-14 |
2014-02-13 |
Exelixis, Inc. |
Methods of using MEK inhibitors
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
CA2672172C
(en)
|
2006-12-22 |
2016-05-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
WO2008080134A2
(en)
|
2006-12-22 |
2008-07-03 |
Rigel Pharmaceuticals, Inc. |
4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
|
US8906922B2
(en)
|
2006-12-29 |
2014-12-09 |
Rigel Pharmaceuticals, Inc. |
Substituted triazoles useful as AXl inhibitors
|
US9650391B2
(en)
|
2006-12-29 |
2017-05-16 |
Rigel Pharmaceuticals Inc. |
N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors
|
DK2114955T3
(da)
|
2006-12-29 |
2013-05-06 |
Rigel Pharmaceuticals Inc |
Broforbundet, bicyklisk aryl og broforbundet, bicyklisk heteroaryl subsitiuerede triazoler, der er anvendelige som axl-inhibitorer
|
CA2710043C
(en)
|
2006-12-29 |
2016-02-09 |
Rigel Pharmaceuticals, Inc. |
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
RS53281B
(en)
|
2006-12-29 |
2014-08-29 |
Rigel Pharmaceuticals Inc. |
POLYCYCLIC HETEROaryl SUBSTITUTED TRIAZOLES USED AS AXL INHIBITORS
|
EP1944369A1
(en)
|
2007-01-12 |
2008-07-16 |
The Centre National de la Recherche Scientifique |
Dbait and its standalone uses thereof
|
CN101663279A
(zh)
|
2007-01-19 |
2010-03-03 |
阿迪生物科学公司 |
Mek抑制剂
|
EP2114983B8
(en)
|
2007-02-07 |
2015-02-18 |
The Regents of the University of Colorado, A Body Corporate |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
US20120232049A1
(en)
|
2007-02-23 |
2012-09-13 |
Eisai R&D Management Co., Ltd. |
Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
|
CN101622015A
(zh)
|
2007-03-05 |
2010-01-06 |
协和发酵麒麟株式会社 |
药物组合物
|
EP3023422A1
(en)
|
2007-03-12 |
2016-05-25 |
YM BioSciences Australia Pty Ltd |
Phenyl amino pyrimidine compounds and uses thereof
|
CA2681516A1
(en)
|
2007-03-22 |
2008-09-25 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of janus kinases
|
IL295053A
(en)
|
2007-03-28 |
2022-09-01 |
Pharmacyclics Llc |
Broton tyrosine kinase inhibitors
|
CN101679313A
(zh)
|
2007-04-13 |
2010-03-24 |
休普基因公司 |
用于治疗癌症或过度增殖性疾病的axl激酶抑制剂
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
GB0714384D0
(en)
|
2007-07-23 |
2007-09-05 |
Ucb Pharma Sa |
theraputic agents
|
JP2010535232A
(ja)
|
2007-07-30 |
2010-11-18 |
アルディア バイオサイエンス,インク. |
Mekの阻害剤としての多形体を含む、n−(アリールアミノ)スルホンアミドの誘導体、および組成物、使用方法、ならびにその調製方法
|
JP5479337B2
(ja)
|
2007-07-30 |
2014-04-23 |
アルディア バイオサイエンス,インク. |
Mek阻害剤およびrafキナーゼ阻害剤の組み合わせ、ならびにその使用
|
PA8792501A1
(es)
|
2007-08-09 |
2009-04-23 |
Sanofi Aventis |
Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
|
US8193181B2
(en)
|
2007-09-05 |
2012-06-05 |
Rigel Pharmaceuticals, Inc. |
Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
|
CA2701275C
(en)
|
2007-10-23 |
2016-06-21 |
F. Hoffmann-La Roche Ag |
Kinase inhibitors
|
AU2008314922B2
(en)
|
2007-10-24 |
2013-08-29 |
Astellas Pharma Inc. |
Azolecarboxamide compound or salt thereof
|
US7935693B2
(en)
|
2007-10-26 |
2011-05-03 |
Rigel Pharmaceuticals, Inc. |
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
|
JP5489235B2
(ja)
|
2007-11-15 |
2014-05-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
N含有複素環式化合物
|
US20110039856A1
(en)
|
2007-11-29 |
2011-02-17 |
Pfizer Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
EP2240494B1
(en)
|
2008-01-21 |
2016-03-30 |
UCB Biopharma SPRL |
Thieno-pyridine derivatives as mek inhibitors
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
RU2493152C2
(ru)
|
2008-02-01 |
2013-09-20 |
Акинион Фармасьютикалз Аб |
Новые соединения, применение и получение их
|
BRPI0907915A2
(pt)
|
2008-02-05 |
2015-07-28 |
Hoffmann La Rocha Ag F |
Piridinonas e piridazinonas
|
US8278452B2
(en)
|
2008-02-22 |
2012-10-02 |
Irm Llc |
Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
|
WO2009111279A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
Pyrazole [3, 4-b] pyridine raf inhibitors
|
CA2716949A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
PE20091561A1
(es)
|
2008-02-29 |
2009-10-30 |
Array Biopharma Inc |
Compuestos inhibidores de raf y metodos para su uso
|
EP2265609B1
(en)
|
2008-02-29 |
2012-09-05 |
Array Biopharma, Inc. |
Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
|
MX2010010012A
(es)
|
2008-03-11 |
2010-10-20 |
Incyte Corp |
Derivados de azetidina y ciclobutano como inhibidores de jak.
|
EP2262807B1
(en)
|
2008-03-19 |
2015-08-12 |
ChemBridge Corporation |
Novel tyrosine kinase inhibitors
|
US8822500B2
(en)
|
2008-03-19 |
2014-09-02 |
Chembridge Corporation |
Tyrosine kinase inhibitors
|
WO2009126933A2
(en)
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
JP2011518786A
(ja)
|
2008-04-14 |
2011-06-30 |
アルデア バイオサイエンシズ,インコーポレイティド |
調製及び使用のための組成物及び方法
|
EP2262772B8
(en)
|
2008-04-16 |
2013-03-13 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Quinoline derivatives as axl kinase inhibitors
|
SG2014015085A
(en)
|
2008-04-16 |
2014-06-27 |
Portola Pharm Inc |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
|
EA024109B1
(ru)
|
2008-04-16 |
2016-08-31 |
Портола Фармасьютиклз, Инк. |
Ингибиторы протеинкиназ
|
WO2009131687A2
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
CA2722326A1
(en)
|
2008-04-24 |
2009-10-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
KR101860057B1
(ko)
|
2008-05-21 |
2018-05-21 |
어리어드 파마슈티칼스, 인코포레이티드 |
키나아제 억제제로서 포스포러스 유도체
|
KR101706784B1
(ko)
|
2008-05-21 |
2017-02-14 |
인사이트 홀딩스 코포레이션 |
2-플루오로-N-메틸-4-[7-(퀴놀린-6-일-메틸)-이미다조[1,2-b][1,2,4]트리아진-2-일]벤즈아미드의 염 및 이의 제조 방법
|
GB0811304D0
(en)
|
2008-06-19 |
2008-07-30 |
Ucb Pharma Sa |
Therapeutic agents
|
EP2328872A1
(en)
|
2008-06-19 |
2011-06-08 |
AstraZeneca AB |
Pyrazole compounds 436
|
PE20110063A1
(es)
|
2008-06-20 |
2011-02-16 |
Genentech Inc |
DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
|
KR20110033223A
(ko)
|
2008-06-20 |
2011-03-30 |
제넨테크, 인크. |
트리아졸로피리딘 jak 억제제 화합물 및 방법
|
CN102066366B
(zh)
|
2008-06-24 |
2014-04-16 |
霍夫曼-拉罗奇有限公司 |
新型取代的吡啶-2-酮和哒嗪-3-酮
|
JP5613156B2
(ja)
|
2008-07-09 |
2014-10-22 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Axl阻害剤として有用な架橋二環ヘテロアリール置換トリアゾール
|
JP5592884B2
(ja)
|
2008-07-09 |
2014-09-17 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Axl阻害剤として有用な多環式ヘテロアリール置換トリアゾール
|
MX2011000661A
(es)
|
2008-07-16 |
2011-05-25 |
Pharmacyclics Inc |
Inhibidores de tirosina cinasa de bruton para el tratamiento de tumores solidos.
|
PE20110560A1
(es)
|
2008-07-18 |
2011-08-29 |
Sanofi Aventis |
NUEVOS DERIVADOS DE TRIAZOLO[4,3-a]PIRIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACION PARTICULARMENTE COMO INHIBIDORES DE MET
|
EA201170223A1
(ru)
|
2008-07-18 |
2011-08-30 |
Санофи-Авентис |
НОВЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И НОВОЕ ПРИМЕНЕНИЕ, В ЧАСТНОСТИ, В КАЧЕСТВЕ ИНГИБИТОРОВ МЕТ
|
FR2933982A1
(fr)
|
2008-07-18 |
2010-01-22 |
Sanofi Aventis |
Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
|
UA107183C2
(uk)
|
2008-08-04 |
2014-12-10 |
|
Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
ES2464461T3
(es)
|
2008-09-22 |
2014-06-02 |
Array Biopharma, Inc. |
Compuestos de imidazo[1,2B]piridazina sustituidos como inhibidores de la TRK cinasa
|
PL3372605T3
(pl)
|
2008-10-22 |
2022-03-07 |
Array Biopharma Inc. |
Podstawione związki pirazolo[1,5-a]pirymidynowe jako inhibitory kinaz trk
|
KR101686685B1
(ko)
|
2008-10-31 |
2016-12-14 |
제넨테크, 인크. |
피라졸로피리미딘 jak 억제제 화합물 및 방법
|
EP2365970B1
(en)
|
2008-11-12 |
2018-03-21 |
Gilead Connecticut, Inc. |
Pyridazinones and their use as btk inhibitors
|
US8217056B2
(en)
|
2008-11-19 |
2012-07-10 |
Vertex Pharmaceuticals Incorporated |
Triazolothiadiazole inhibitor of c-Met protein kinase
|
EP3123864A1
(en)
|
2008-12-08 |
2017-02-01 |
Gilead Connecticut, Inc. |
Imidazopyrazine syk inhibitors
|
ES2744541T3
(es)
|
2008-12-08 |
2020-02-25 |
Gilead Connecticut Inc |
Inhibidores de imidazopirazina Syk
|
ITMI20082336A1
(it)
|
2008-12-29 |
2010-06-30 |
Univ Parma |
Composti inibitori irreversibili di egfr con attivita' antiproliferativa
|
KR20110100679A
(ko)
|
2009-01-13 |
2011-09-14 |
글락소 그룹 리미티드 |
Syk 키나아제의 억제제로서 피리미딘카르복사미드 유도체
|
JOP20190230A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
AU2010204578B2
(en)
|
2009-01-16 |
2016-05-12 |
Rigel Pharmaceuticals, Inc. |
AXL inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
|
US8765727B2
(en)
|
2009-01-23 |
2014-07-01 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
FR2941952B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
FR2941951B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
US20100204221A1
(en)
|
2009-02-09 |
2010-08-12 |
Hariprasad Vankayalapati |
Pyrrolopyrimidinyl axl kinase inhibitors
|
US8673919B2
(en)
|
2009-03-27 |
2014-03-18 |
Ardea Biosciences, Inc. |
Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
|
EA201101533A1
(ru)
|
2009-04-21 |
2012-05-30 |
Новартис Аг |
Гетероциклические соединения в качестве ингибиторов mek
|
JP5656976B2
(ja)
|
2009-04-29 |
2015-01-21 |
ローカス ファーマシューティカルズ インコーポレイテッド |
ピロロトリアジン化合物
|
CN102482277B
(zh)
|
2009-05-05 |
2017-09-19 |
达纳-法伯癌症研究所有限公司 |
表皮生长因子受体抑制剂及治疗障碍的方法
|
KR20120030447A
(ko)
|
2009-05-22 |
2012-03-28 |
인사이트 코포레이션 |
Jak 저해물질로서 3-[4-(7h-피롤로[2,3-d]피리미딘-4-일)-1h-피라졸-1-일]옥탄- 또는 헵탄-니트릴
|
TWI531367B
(zh)
|
2009-06-10 |
2016-05-01 |
中外製藥股份有限公司 |
四環化合物
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
EP2443123B1
(en)
|
2009-06-15 |
2017-04-05 |
Rigel Pharmaceuticals, Inc. |
Small molecule inhibitors of spleen tyrosine kinase (syk)
|
CN102134218A
(zh)
|
2009-06-15 |
2011-07-27 |
凯美隆(北京)药业技术有限公司 |
6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
JP2013501002A
(ja)
|
2009-07-30 |
2013-01-10 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Sykキナーゼ阻害剤としての化合物および組成物
|
TW201105669A
(en)
|
2009-07-30 |
2011-02-16 |
Irm Llc |
Compounds and compositions as Syk kinase inhibitors
|
WO2011025951A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
WO2011025965A1
(en)
|
2009-08-28 |
2011-03-03 |
Genentech, Inc. |
Raf inhibitor compounds and methods of use thereof
|
WO2011025938A2
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
CN102712635A
(zh)
|
2009-08-28 |
2012-10-03 |
阵列生物制药公司 |
用于抑制raf激酶的1h-吡唑并[3,4-b]吡啶化合物
|
US9029359B2
(en)
|
2009-09-04 |
2015-05-12 |
Biogen Idec Ma, Inc. |
Heteroaryl Btk inhibitors
|
WO2011029046A1
(en)
|
2009-09-04 |
2011-03-10 |
Biogen Idec Ma Inc. |
Bruton's tyrosine kinase inhibitors
|
WO2011039527A1
(en)
|
2009-09-30 |
2011-04-07 |
Merck Sharp & Dohme Ltd |
Formulations for c-met kinase inhibitors
|
EP2488507B1
(en)
|
2009-10-13 |
2014-12-17 |
Allostem Therapeutics LLC |
Novel mek inhibitors, useful in the treatment of diseases
|
RS59181B1
(sr)
|
2009-10-16 |
2019-10-31 |
Novartis Ag |
Kombinacija koja sadrži inhibitor mek i inhibitor b-raf
|
EP2496575B1
(en)
|
2009-11-04 |
2014-04-30 |
Novartis AG |
Heterocyclic sulfonamide derivatives useful as mek inhibitors
|
EP2512246B1
(en)
|
2009-12-17 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
CA2782889C
(en)
|
2009-12-17 |
2014-08-05 |
Merck Canada Inc. |
Aminopyrimidines as syk inhibitors
|
EP3081567A3
(en)
|
2009-12-23 |
2016-11-16 |
ArQule, Inc. |
Methods for preparing of (-)trans-3-(5,6-dihydro-4h-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1h-indol-3-yl)pyrrolidine-2,5-dione
|
PE20130188A1
(es)
|
2009-12-23 |
2013-02-21 |
Takeda Pharmaceutical |
Pirrolidinonas heteroaromaticas fusionadas como inhibidores de syk
|
EP2338888A1
(en)
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridine derivatives as JAK inhibitors
|
EP2937345B1
(en)
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
US8962665B2
(en)
|
2010-01-12 |
2015-02-24 |
Ab Science |
Thiazole and oxazole kinase inhibitors
|
CA2786245A1
(en)
|
2010-01-29 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and their use as syk kinase inhibitors
|
MX350010B
(es)
|
2010-03-11 |
2017-08-23 |
Gilead Connecticut Inc |
Inhibidores syk de imidazopiridinas.
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
US8957216B2
(en)
|
2010-03-24 |
2015-02-17 |
Amitech Therapeutic Solutions, Inc. |
Heterocyclic compounds useful for kinase inhibition
|
WO2011121223A1
(fr)
|
2010-03-30 |
2011-10-06 |
Sanofi-Aventis |
Derives de 6-(alkyl- ou cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles: preparation, application comme medicaments et utilisation comme inhibiteurs de met
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
CA2796967C
(en)
|
2010-05-04 |
2015-12-01 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
WO2011143646A1
(en)
|
2010-05-14 |
2011-11-17 |
OSI Pharmaceuticals, LLC |
Fused bicyclic kinase inhibitors
|
MX2012013378A
(es)
|
2010-05-20 |
2013-01-24 |
Hoffmann La Roche |
Derivados de pirrolo [2, 3-b] pirazina-7-carboxamida y sus uso como inhibidores de cinasa janus (jak) y cinasa tirosina del brazo (syk).
|
TWI496785B
(zh)
|
2010-05-20 |
2015-08-21 |
Hoffmann La Roche |
吡咯并吡激酶抑制劑
|
US8263777B2
(en)
|
2010-05-27 |
2012-09-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase
|
US8669256B2
(en)
|
2010-05-28 |
2014-03-11 |
Merck Sharp & Dohme B.V. |
Substituted thieno[2,3-b]pyrazine compounds as modulators of B-Raf kinase activity
|
SG185617A1
(en)
|
2010-05-31 |
2012-12-28 |
Ono Pharmaceutical Co |
Purinone derivative
|
NZ789041A
(en)
|
2010-06-03 |
2023-09-29 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|
PT3135301T
(pt)
|
2010-06-22 |
2018-07-16 |
Inst Curie |
Sistema de administração otimizado in vivo com agentes endossomolíticos para conjugados de ácidos nucleicos
|
EP2589592B1
(en)
|
2010-06-30 |
2018-08-22 |
FUJIFILM Corporation |
Novel nicotinamide derivatives or salts thereof
|
WO2012005299A1
(ja)
|
2010-07-07 |
2012-01-12 |
日本新薬株式会社 |
Rosチロシンキナーゼ阻害剤
|
WO2012006960A1
(en)
|
2010-07-14 |
2012-01-19 |
Zhejiang Beta Pharma Inc. |
NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
KR20130091331A
(ko)
|
2010-07-16 |
2013-08-16 |
교와 핫꼬 기린 가부시키가이샤 |
함질소 방향족 복소환 유도체
|
AR085183A1
(es)
|
2010-07-30 |
2013-09-18 |
Lilly Co Eli |
Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
CA2807051A1
(en)
|
2010-08-10 |
2012-02-16 |
Celgene Avilomics Research, Inc. |
Besylate salt of a btk inhibitor
|
CA2808210C
(en)
|
2010-08-20 |
2019-10-01 |
Chugai Seiyaku Kabushiki Kaisha |
Tetracyclic compounds having alk inhibitory activity and compositions thereof
|
MX2013002199A
(es)
|
2010-08-27 |
2013-03-18 |
Merck Patent Gmbh |
Derivados de furopiridina.
|
CN103068828B
(zh)
|
2010-08-27 |
2015-09-09 |
默克专利股份公司 |
三唑并吡嗪衍生物
|
EP2423208A1
(en)
|
2010-08-28 |
2012-02-29 |
Lead Discovery Center GmbH |
Pharmaceutically active compounds as Axl inhibitors
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
US8664244B2
(en)
|
2010-09-12 |
2014-03-04 |
Advenchen Pharmaceuticals, LLC |
Compounds as c-Met kinase inhibitors
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
WO2012048258A2
(en)
|
2010-10-08 |
2012-04-12 |
Xcovery Holding Company, Llc |
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
|
WO2012061418A2
(en)
|
2010-11-01 |
2012-05-10 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as syk modulators
|
CN102020651B
(zh)
|
2010-11-02 |
2012-07-18 |
北京赛林泰医药技术有限公司 |
6-芳基氨基吡啶酮甲酰胺mek抑制剂
|
CN102532141A
(zh)
|
2010-12-08 |
2012-07-04 |
中国科学院上海药物研究所 |
[1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
BR112013021638A2
(pt)
|
2011-02-25 |
2016-08-02 |
Irm Llc |
"compostos inibidores de trk, seu uso e composições que os compreendem"
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
ES2588680T3
(es)
|
2011-03-28 |
2016-11-04 |
F. Hoffmann-La Roche Ag |
Compuestos de tiazolopirimidina
|
WO2012135800A1
(en)
|
2011-04-01 |
2012-10-04 |
University Of Utah Research Foundation |
Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
|
EP2694486B1
(en)
|
2011-04-01 |
2018-01-10 |
University of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
MX2013011612A
(es)
|
2011-04-05 |
2013-10-17 |
Pfizer Ltd |
Derivados de pirrolo[2,3-d]pirimidina como inhibidores de quinasa relacionados con tropomiosina.
|
EP2704571B1
(en)
|
2011-05-04 |
2020-04-22 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
RU2013154412A
(ru)
|
2011-05-10 |
2015-06-20 |
Мерк Шарп И Доум Корп. |
Аминопиримидины в качестве ингибиторов syc
|
US9120785B2
(en)
|
2011-05-10 |
2015-09-01 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as Syk inhibitors
|
BR112013029201B1
(pt)
|
2011-05-13 |
2022-08-09 |
Array Biopharma Inc |
Compostos de pirrolidinil ureia e pirrolidinil tioureia, seu processo de preparação, seu uso e composições farmacêuticas
|
EP2527440A1
(en)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
WO2012167423A1
(en)
|
2011-06-08 |
2012-12-13 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as novel syk inhibitors
|
SG10201801668WA
(en)
|
2011-06-10 |
2018-03-28 |
Merck Patent Gmbh |
Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
|
CN102816162B
(zh)
|
2011-06-10 |
2016-04-27 |
中国科学院广州生物医药与健康研究院 |
嘧啶并嘧啶酮类化合物及其药用组合物和应用
|
CN102393896B
(zh)
|
2011-07-11 |
2014-08-27 |
成都西谷曙光数字技术有限公司 |
一种简单精确的射频定位系统和方法
|
US9102673B2
(en)
|
2011-07-12 |
2015-08-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors
|
JP2014522860A
(ja)
|
2011-07-19 |
2014-09-08 |
メルク・シャープ・アンド・ドーム・ベー・フェー |
Btk阻害剤としての4−イミダゾピリダジン−1−イル−ベンズアミドおよび4−イミダゾトリアジン−1−イル−ベンズアミド
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
UA115312C2
(uk)
|
2011-07-19 |
2017-10-25 |
Мерк Шарп І Доум Б.В. |
4-імідазопіридазин-1-ілбензаміди і 4-імідазотриазин-1-ілбензаміди як втк-інгібітори
|
CN103732588B
(zh)
|
2011-07-27 |
2016-10-12 |
南京奥昭生物科技有限公司 |
螺环分子作为蛋白激酶抑制剂
|
KR101924247B1
(ko)
|
2011-07-27 |
2019-02-22 |
에이비 사이언스 |
선택적 프로테인 키나제 저해제로서 옥사졸 및 티아졸 유도체
|
CA2845785A1
(en)
|
2011-09-01 |
2013-03-07 |
Irm Llc |
Compounds and compositions as c-kit kinase inhibitors
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|
EP2751105A1
(en)
|
2011-09-01 |
2014-07-09 |
Irm Llc |
Compounds and compositions as c-kit kinase inhibitors
|
EP2751104B1
(en)
|
2011-09-01 |
2019-09-25 |
Novartis AG |
Compounds and compositions as c-kit kinase inhibitors
|
EP3332785B1
(en)
|
2011-09-14 |
2020-05-06 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
WO2013047813A1
(ja)
|
2011-09-30 |
2013-04-04 |
大鵬薬品工業株式会社 |
1,2,4-トリアジン-6-カルボキサミド誘導体
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
EP2763974B1
(en)
|
2011-10-05 |
2016-09-14 |
Merck Sharp & Dohme Corp. |
Phenyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
US9216173B2
(en)
|
2011-10-05 |
2015-12-22 |
Merck Sharp & Dohme Corp. |
2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
JP6506555B2
(ja)
|
2011-10-19 |
2019-04-24 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼ(Btk)阻害剤の使用
|
WO2013064445A1
(en)
|
2011-11-01 |
2013-05-10 |
F. Hoffmann-La Roche Ag |
Imidazopyridazine compounds
|
AR088642A1
(es)
|
2011-11-03 |
2014-06-25 |
Genentech Inc |
Compuestos de piperazina alquilados
|
US8669251B2
(en)
|
2011-11-03 |
2014-03-11 |
Genentech, Inc. |
8-fluorophthalazin-1(2H)-one compounds
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
EP3045453A1
(en)
|
2011-11-14 |
2016-07-20 |
Cephalon, Inc. |
Uracil derivatives as axl and c-met kinase inhibitors
|
LT2786996T
(lt)
|
2011-11-29 |
2017-01-10 |
Ono Pharmaceutical Co., Ltd. |
Purinono darinio hidrochloridas
|
CN104114553B
(zh)
|
2011-12-12 |
2017-03-01 |
雷迪博士实验室有限公司 |
作为原肌球蛋白受体激酶(Trk)抑制剂的取代的吡唑并[1,5‑a]吡啶
|
JP6075736B2
(ja)
|
2011-12-21 |
2017-02-08 |
ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. |
ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
|
DK2799431T3
(en)
|
2011-12-28 |
2018-03-26 |
Fujifilm Corp |
Hitherto unknown nicotinamide derivatives or salts thereof
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
MX352928B
(es)
|
2012-01-10 |
2017-12-13 |
Hoffmann La Roche |
Compuestos de piridazina-amida.
|
EP2802590B1
(en)
|
2012-01-10 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Thienopyrimidine compounds
|
CN103204822B
(zh)
|
2012-01-17 |
2014-12-03 |
上海科州药物研发有限公司 |
作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途
|
CN103204844A
(zh)
|
2012-01-17 |
2013-07-17 |
上海艾力斯医药科技有限公司 |
氨基杂芳基化合物及其制备方法与应用
|
AU2013210403B2
(en)
|
2012-01-19 |
2016-01-14 |
Taiho Pharmaceutical Co., Ltd. |
3,5-disubstituted alkynylbenzene compound and salt thereof
|
JP6062962B2
(ja)
|
2012-01-20 |
2017-01-18 |
ジェノスコ |
置換ピリミジン化合物およびsyk阻害剤としてのそれらの使用
|
SI2810937T1
(sl)
|
2012-01-31 |
2017-01-31 |
Daiichi Sankyo Company, Limited |
Derivat piridona
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
WO2013124869A2
(en)
|
2012-02-21 |
2013-08-29 |
Amrita Vishwa Vidyapeetham University |
The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
|
AU2013224420B2
(en)
|
2012-02-21 |
2016-12-15 |
Merck Patent Gmbh |
Furopyridine derivatives
|
US9120804B2
(en)
|
2012-02-21 |
2015-09-01 |
Merck Patent Gmbh |
8-substituted 2-amino-[1,2,4] triazolo [1, 5-A] pyrazines as Syk tryrosine kinase inhibitors and GCN2 serin kinase inhibitors
|
EP2817306B1
(en)
|
2012-02-21 |
2015-09-16 |
Merck Patent GmbH |
Cyclic diaminopyrimidine derivatives as syk inhibitors
|
KR102032007B1
(ko)
|
2012-02-28 |
2019-10-14 |
아스텔라스세이야쿠 가부시키가이샤 |
질소 함유 방향족 헤테로환 화합물
|
BR112014022713B1
(pt)
|
2012-03-14 |
2021-09-08 |
Lupin Limited |
Composto, sal farmaceuticamente aceitável e composição farmacêutica
|
CN104302178B
(zh)
|
2012-03-15 |
2018-07-13 |
西建卡尔有限责任公司 |
表皮生长因子受体激酶抑制剂的固体形式
|
CA2868156C
(en)
|
2012-03-22 |
2020-07-28 |
Genosco |
Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
|
US9365566B2
(en)
|
2012-03-27 |
2016-06-14 |
Takeda Pharmaceutical Company Limited |
Cinnoline derivatives
|
RU2643326C2
(ru)
|
2012-03-30 |
2018-01-31 |
Новартис Аг |
Ингибитор рецептора фрф для применения в лечении гипофосфатемических заболеваний
|
CN104245701A
(zh)
|
2012-04-03 |
2014-12-24 |
诺华有限公司 |
有酪氨酸激酶抑制剂的组合产品和其应用
|
WO2013152135A1
(en)
|
2012-04-04 |
2013-10-10 |
Dawei Zhang |
Substituted quinolines as bruton's tyrosine kinases inhibitors
|
WO2013157540A1
(ja)
|
2012-04-17 |
2013-10-24 |
富士フイルム株式会社 |
含窒素複素環化合物またはその塩
|
US20150056193A1
(en)
|
2012-04-18 |
2015-02-26 |
Cell Signaling Technology, Inc. |
Egfr and ros1 kinase in cancer
|
TW201350479A
(zh)
|
2012-04-26 |
2013-12-16 |
Ono Pharmaceutical Co |
Trk阻害化合物
|
WO2013170671A1
(zh)
|
2012-05-14 |
2013-11-21 |
华东理工大学 |
蝶啶酮衍生物及其作为egfr、blk、flt3抑制剂的应用
|
WO2013176970A1
(en)
|
2012-05-22 |
2013-11-28 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
CA2872645A1
(en)
|
2012-05-30 |
2013-12-05 |
Nippon Shinyaku Co., Ltd. |
Aromatic heterocyclic derivative and pharmaceutical
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
CA2876689C
(en)
|
2012-06-13 |
2022-04-26 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
MX2014015271A
(es)
|
2012-06-14 |
2015-03-05 |
Lilly Co Eli |
Inhibidor de jak1 y jak2.
|
US9242984B2
(en)
|
2012-06-20 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as Syk inhibitors
|
EP2863913B1
(en)
|
2012-06-20 |
2018-09-12 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
WO2013192098A1
(en)
|
2012-06-22 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
US9416111B2
(en)
|
2012-06-22 |
2016-08-16 |
Merck Sharp & Dohme Corp. |
Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
|
TWI520962B
(zh)
|
2012-06-29 |
2016-02-11 |
|
As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
|
CA2782774A1
(en)
|
2012-07-06 |
2014-01-06 |
Pharmascience Inc. |
Protein kinase inhibitors
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
WO2014023385A1
(en)
|
2012-08-07 |
2014-02-13 |
Merck Patent Gmbh |
Pyridopyrimidine derivatives as protein kinase inhibitors
|
NZ703607A
(en)
|
2012-08-10 |
2018-02-23 |
Boehringer Ingelheim Int |
Heteroaromatic compounds as bruton’s tyrosine kinase (btk) inhibitors
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
MX2015002006A
(es)
|
2012-08-13 |
2015-06-02 |
Novartis Ag |
Derivados de heteroaril-cicloalquildiamina biciclicos como inhibidores de tirosina cinasas del bazo (syk).
|
US9353066B2
(en)
|
2012-08-20 |
2016-05-31 |
Merck Sharp & Dohme Corp. |
Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
|
KR20150043323A
(ko)
|
2012-08-21 |
2015-04-22 |
에프. 호프만-라 로슈 아게 |
비장 티로신 키나제 억제제로서 피롤로[2,3-b]피라진
|
CN103122000B
(zh)
|
2012-09-03 |
2013-12-25 |
中美冠科生物技术(太仓)有限公司 |
用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
|
WO2014039899A1
(en)
|
2012-09-10 |
2014-03-13 |
Principia Biopharma Inc. |
Pyrazolopyrimidine compounds as kinase inhibitors
|
CA2884921A1
(en)
|
2012-09-18 |
2014-03-27 |
Ziarco Pharma Ltd |
2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
|
MY170904A
(en)
|
2012-09-25 |
2019-09-13 |
Chugai Pharmaceutical Co Ltd |
Ret inhibitor
|
US9469654B2
(en)
|
2012-09-27 |
2016-10-18 |
Portola Pharmaceuticals, Inc. |
Bicyclic oxa-lactam kinase inhibitors
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
CA2887435A1
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
EP2903971B1
(en)
|
2012-10-04 |
2019-06-12 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
JP2015534959A
(ja)
|
2012-10-19 |
2015-12-07 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Sykの阻害剤
|
CN104640850A
(zh)
|
2012-10-26 |
2015-05-20 |
霍夫曼-拉罗奇有限公司 |
3,4-二取代的1h-吡唑和4,5-二取代的噻唑的syk抑制剂
|
JP6178861B2
(ja)
|
2012-11-02 |
2017-08-09 |
ファイザー・インク |
ブルトン型チロシンキナーゼ阻害剤
|
CN102977014B
(zh)
|
2012-11-05 |
2015-01-07 |
沈阳药科大学 |
新的喹啉类化合物及其用途
|
WO2014074422A1
(en)
|
2012-11-07 |
2014-05-15 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
LT2922844T
(lt)
|
2012-11-13 |
2018-03-26 |
Array Biopharma, Inc. |
N-pirolidinilo, n'-pirazolil-karbamido, tiokarbamido, guanidino ir cianoguanidino junginiai kaip trka kinazės inhibitoriai
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9546156B2
(en)
|
2012-11-13 |
2017-01-17 |
Array Biopharma Inc. |
N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
CA2890934A1
(en)
|
2012-11-15 |
2014-05-22 |
Pharmacyclics, Inc. |
Pyrrolopyrimidine compounds as kinase inhibitors
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
WO2014086032A1
(en)
|
2012-12-07 |
2014-06-12 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as syk inhibitors
|
US9624210B2
(en)
|
2012-12-12 |
2017-04-18 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
WO2014105958A2
(en)
|
2012-12-26 |
2014-07-03 |
Medivation Technologies, Inc. |
Fused pyrimidine compounds and use thereof
|
CN104995184B
(zh)
|
2012-12-28 |
2018-01-02 |
晶体基因技术株式会社 |
作为btk激酶抑制剂的2,3‑二氢异吲哚‑1‑酮诱导体与含此类的药学组合物
|
US9745320B2
(en)
|
2013-01-18 |
2017-08-29 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd. |
Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof
|
TW201441234A
(zh)
|
2013-01-23 |
2014-11-01 |
Merck Sharp & Dohme |
Btk抑制劑
|
WO2014113932A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
US9475813B2
(en)
|
2013-02-08 |
2016-10-25 |
Nissan Chemical Industries, Ltd. |
Tricyclic pyrrolopyridine compound, and JAK inhibitor
|
TWI663161B
(zh)
|
2013-02-19 |
2019-06-21 |
Ono Pharmaceutical Co., Ltd. |
Trk抑制化合物
|
AR094812A1
(es)
|
2013-02-20 |
2015-08-26 |
Eisai R&D Man Co Ltd |
Derivado de piridina monocíclico como inhibidor del fgfr
|
WO2014130693A1
(en)
|
2013-02-25 |
2014-08-28 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
AU2014249158B2
(en)
|
2013-03-11 |
2016-07-28 |
Ignyta, Inc. |
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor
|
JO3377B1
(ar)
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
US8895750B2
(en)
|
2013-03-14 |
2014-11-25 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic compounds as BTK inhibitors
|
JP6495886B2
(ja)
|
2013-03-15 |
2019-04-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Btk阻害剤としての複素環式芳香族化合物
|
KR20150130311A
(ko)
|
2013-03-19 |
2015-11-23 |
머크 샤프 앤드 돔 코포레이션 |
야누스 키나제 억제제로서의 n-(2-시아노 헤테로시클릴)피라졸로 피리돈
|
KR101737723B1
(ko)
|
2013-04-02 |
2017-05-18 |
에프. 호프만-라 로슈 아게 |
브루톤 티로신 키나아제의 억제제
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
US10072298B2
(en)
*
|
2013-04-17 |
2018-09-11 |
Life Technologies Corporation |
Gene fusions and gene variants associated with cancer
|
HUE036571T2
(hu)
|
2013-04-19 |
2018-07-30 |
Incyte Holdings Corp |
Biciklusos heterociklusok mint FGFR inhibitorok
|
US9499534B2
(en)
|
2013-04-26 |
2016-11-22 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
US9745295B2
(en)
|
2013-04-26 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
KR102211310B1
(ko)
|
2013-05-10 |
2021-02-03 |
장쑤 한서 파마슈티칼 캄파니 리미티드 |
[1,2,4]트라이아졸[4,3-에이]피리딘 유도체, 그의 제조 방법 또는 그의 의학적 용도
|
PT3231801T
(pt)
|
2013-05-17 |
2019-05-24 |
Incyte Corp |
Sal de bipirazole como inibidor da jak
|
WO2014187319A1
(en)
|
2013-05-21 |
2014-11-27 |
Jiangsu Medolution Ltd |
Substituted pyrazolopyrimidines as kinases inhibitors
|
MX2015016332A
(es)
|
2013-05-29 |
2016-07-20 |
Cephalon Inc |
Inhibidores de alk biciclicos fusionados.
|
AR096654A1
(es)
|
2013-06-20 |
2016-01-27 |
Ab Science |
Derivados de benzimidazol como inhibidores selectivos de proteína quinasa
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
LT3013337T
(lt)
|
2013-06-26 |
2019-01-10 |
Abbvie Inc. |
Pirminiai karboksamidai kaip btk inhibitoriai
|
EP3013798B1
(en)
|
2013-06-28 |
2018-06-27 |
BeiGene, Ltd. |
Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
|
EP3016953A4
(en)
|
2013-07-02 |
2017-03-01 |
Pharmacyclics, LLC |
Purinone compounds as kinase inhibitors
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
EP3628749A1
(en)
|
2013-07-30 |
2020-04-01 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
EA031601B1
(ru)
|
2013-07-31 |
2019-01-31 |
Джилид Сайэнс, Инк. |
Ингибиторы syk
|
RU2712220C2
(ru)
|
2013-07-31 |
2020-01-27 |
Мерк Патент Гмбх |
Пиридины, пиримидины и пиразины в качестве ингибиторов тирозинкиназы брутона и их применение
|
US10028956B2
(en)
|
2013-08-02 |
2018-07-24 |
Ignyta, Inc. |
Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents
|
DK2947086T3
(en)
|
2013-08-12 |
2018-03-19 |
Taiho Pharmaceutical Co Ltd |
UNKNOWN CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
CN106029099A
(zh)
|
2013-08-28 |
2016-10-12 |
诺华股份有限公司 |
用于治疗细胞增殖性疾病的alk抑制剂与cdk抑制剂的组合
|
MX368781B
(es)
|
2013-09-18 |
2019-10-16 |
Beijing Hanmi Pharmaceutical Co Ltd |
Compuesto inhibidor de las actividades de las cinasas btk y/o jak3.
|
WO2015039333A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2015039334A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
RU2677884C2
(ru)
|
2013-09-30 |
2019-01-22 |
Гуанчжоу Иннокэа Фарма Тек Ко., Лтд. |
Замещенные никотинимидные ингибиторы втк, их получение и применение в терапии раковых, воспалительных и аутоиммунных заболеваний
|
SG11201602421VA
(en)
|
2013-09-30 |
2016-04-28 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
EP3059227B1
(en)
|
2013-10-16 |
2019-06-26 |
FUJIFILM Corporation |
Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and flt3 inhibitor
|
PT3060562T
(pt)
|
2013-10-21 |
2021-09-02 |
Genosco |
Compostos de pirimidina substituídos e sua utilização como inibidores da syk
|
LT3060550T
(lt)
|
2013-10-21 |
2019-08-12 |
Merck Patent Gmbh |
Heteroarilo junginiai, kaip btk inhibitoriai, ir jų panaudojimas
|
ES2868450T3
(es)
|
2013-10-25 |
2021-10-21 |
Shanghai hengrui pharmaceutical co ltd |
Derivados piridicos de cetonas, método de preparación de los mismos y aplicación farmacéutica de los mismos
|
JP6203954B2
(ja)
|
2013-10-25 |
2017-09-27 |
ノバルティス アーゲー |
Fgfr4阻害剤としての縮環二環式ピリジル誘導体
|
JP6493218B2
(ja)
|
2013-11-08 |
2019-04-03 |
小野薬品工業株式会社 |
ピロロピリミジン誘導体
|
CN104447640B
(zh)
|
2013-12-02 |
2016-07-13 |
北京键凯科技有限公司 |
3-呋喃基-2-氰基-2-丙烯酰胺衍生物及其制备方法、药物组合物和用途
|
CA2932609A1
(en)
|
2013-12-05 |
2015-06-11 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
TWI731317B
(zh)
|
2013-12-10 |
2021-06-21 |
美商健臻公司 |
原肌球蛋白相關之激酶(trk)抑制劑
|
US9783531B2
(en)
|
2013-12-20 |
2017-10-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
US9834554B2
(en)
|
2013-12-20 |
2017-12-05 |
Merck Sharp & Dohme Corp. |
BTK inhibitors
|
EP3082809B1
(en)
|
2013-12-20 |
2021-01-20 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
EP3083560B1
(en)
|
2013-12-20 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
EP3083559B1
(en)
|
2013-12-20 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
UY35898A
(es)
|
2013-12-23 |
2015-07-31 |
Gilead Sciences Inc |
?compuestos inhibidores de syk y composiciones que los comprenden?.
|
ES2654931T3
(es)
|
2013-12-26 |
2018-02-15 |
Ignyta, Inc. |
Derivados de pirazolo[1,5-a]piridina y procedimientos de uso de los mismos
|
WO2015116485A1
(en)
|
2014-01-29 |
2015-08-06 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds as btk inhibitors
|
CN105916859A
(zh)
|
2014-02-03 |
2016-08-31 |
卡迪拉保健有限公司 |
杂环化合物
|
SI3103453T1
(sl)
|
2014-02-04 |
2020-10-30 |
Astellas Pharma Inc. |
Medicinski sestavek, ki obsega diamino heterociklično karboksamidno spojino kot aktivno sestavino
|
WO2015127629A1
(en)
|
2014-02-27 |
2015-09-03 |
Jiangsu Ascentage Biomed Development Inc. |
Indoloquinolone compounds as anaplastic lymphoma kinase (alk) inhibitors
|
EP3116506B1
(en)
|
2014-03-13 |
2019-04-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
LT3119772T
(lt)
|
2014-03-19 |
2019-08-26 |
Boehringer Ingelheim International Gmbh |
Heteroarilo sik inhibitoriai
|
RU2016139031A
(ru)
|
2014-03-24 |
2018-04-25 |
Аб Сьянс |
Производные оксазола, замещенные диазаспироалкалоном, в качестве ингибиторов тирозинкиназы селезенки
|
WO2015143652A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143654A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
MX367913B
(es)
|
2014-03-27 |
2019-09-11 |
Janssen Pharmaceutica Nv |
Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirimidina y 2,3-dihidro-1h-imidazo[1,2-b]pirazol sustituidos como inhibidores de ros1.
|
EA032255B1
(ru)
|
2014-03-27 |
2019-04-30 |
Янссен Фармацевтика Нв |
ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИНА И ПРОИЗВОДНЫЕ 5,6,7,8-ТЕТРАГИДРО-4H-ПИРАЗОЛО[1,5-a][1,4]ДИАЗЕПИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Ros1
|
CN106458914B
(zh)
|
2014-03-28 |
2020-01-14 |
常州捷凯医药科技有限公司 |
作为axl抑制剂的杂环化合物
|
CN105017256A
(zh)
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
CN105085474B
(zh)
|
2014-05-07 |
2018-05-18 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
CN106459050B
(zh)
|
2014-05-14 |
2019-02-26 |
日产化学株式会社 |
三环化合物以及jak抑制剂
|
MY191956A
(en)
|
2014-05-15 |
2022-07-20 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor
|
WO2015180685A1
(zh)
|
2014-05-30 |
2015-12-03 |
北京浦润奥生物科技有限责任公司 |
Alk激酶抑制剂及其制备方法和应用
|
CA2952787A1
(en)
|
2014-06-17 |
2015-12-23 |
Korea Research Institute Of Chemical Technology |
Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient
|
EP3157921A1
(en)
|
2014-06-23 |
2017-04-26 |
Dr. Reddy's Laboratories Ltd. |
Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain
|
TWI690525B
(zh)
|
2014-07-07 |
2020-04-11 |
日商第一三共股份有限公司 |
具有四氫吡喃基甲基之吡啶酮衍生物及其用途
|
TW201617074A
(zh)
|
2014-07-14 |
2016-05-16 |
吉李德科學股份有限公司 |
Syk(脾酪胺酸激酶)抑制劑
|
US9533991B2
(en)
|
2014-08-01 |
2017-01-03 |
Pharmacyclics Llc |
Inhibitors of Bruton's tyrosine kinase
|
JP6618120B2
(ja)
|
2014-08-06 |
2019-12-11 |
塩野義製薬株式会社 |
TrkA阻害活性を有する複素環および炭素環誘導体
|
NO2721710T3
(US20110158925A1-20110630-C00042.png)
|
2014-08-21 |
2018-03-31 |
|
|
KR101710127B1
(ko)
|
2014-08-29 |
2017-02-27 |
한화제약주식회사 |
야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민
|
US20170281641A1
(en)
|
2014-09-03 |
2017-10-05 |
Genzyme Corporation |
CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS
|
CN105524068B
(zh)
|
2014-09-30 |
2017-11-24 |
上海海雁医药科技有限公司 |
氮杂双环衍生物、其制法与医药上的用途
|
WO2016054483A1
(en)
|
2014-10-03 |
2016-04-07 |
Novartis Ag |
Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
|
BR112017006305B1
(pt)
|
2014-10-06 |
2024-02-20 |
Merck Patent Gmbh |
Compostos heteroarila, seus usos, e composição farmacêutica
|
DK3205650T3
(da)
|
2014-10-11 |
2021-09-13 |
Shanghai Hansoh Biomedical Co Ltd |
Egfr-hæmmer og fremstilling og anvendelse deraf
|
CN107108555B
(zh)
|
2014-10-24 |
2020-12-01 |
百时美施贵宝公司 |
三环阻转异构体化合物
|
WO2016066726A2
(en)
|
2014-10-30 |
2016-05-06 |
Sandoz Ag |
Active acrylamides
|
CN105085489B
(zh)
|
2014-11-05 |
2019-03-01 |
益方生物科技(上海)有限公司 |
嘧啶或吡啶类化合物、其制备方法和医药用途
|
WO2016079763A1
(en)
|
2014-11-20 |
2016-05-26 |
Council Of Scientific & Industrial Research |
Novel benzimidazole based egfr inhibitors
|
CN105601573B
(zh)
|
2014-11-24 |
2021-07-02 |
中国科学院上海药物研究所 |
2-氨基嘧啶类化合物及其药物组合物和应用
|
SG11201704090WA
(en)
|
2014-12-11 |
2017-06-29 |
Bayer Pharma AG |
Use of pan fgfr inhibitors and method of identifying patients with cancer eligible for treatment with a pan fgfr inhibitor
|
ES2746839T3
(es)
|
2014-12-18 |
2020-03-09 |
Pfizer |
Derivados de pirimidina y triazina y su uso como inhibidores de AXL
|
EP3239147B9
(en)
|
2014-12-25 |
2020-01-08 |
Ono Pharmaceutical Co., Ltd. |
Quinoline derivative
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
WO2016106627A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
CN104530063B
(zh)
|
2015-01-13 |
2017-01-18 |
北京赛特明强医药科技有限公司 |
喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
|
CN105837576B
(zh)
|
2015-01-14 |
2019-03-26 |
湖北生物医药产业技术研究院有限公司 |
Btk抑制剂
|
KR101864561B1
(ko)
|
2015-01-20 |
2018-06-04 |
우시 포춘 파마슈티컬 컴퍼니 리미티드 |
Jak 억제제
|
US10336723B2
(en)
|
2015-01-23 |
2019-07-02 |
Gvk Biosciences Private Limited |
Inhibitors of TrkA kinase
|
CA2974442A1
(en)
|
2015-02-03 |
2016-08-11 |
Trillium Therapeutics Inc. |
Novel fluorinated derivatives as egfr inhibitors useful for treating cancers
|
EP3253750B1
(en)
|
2015-02-03 |
2019-04-10 |
Council of Scientific and Industrial Research |
Novel flavone based egfr inhibitors and process for preparation thereof
|
EP3259269B9
(en)
|
2015-02-20 |
2020-03-04 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
WO2016161572A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
SG11201707638UA
(en)
|
2015-04-14 |
2017-10-30 |
Qurient Co Ltd |
Quinoline derivatives as tam rtk inhibitors
|
CA2982493C
(en)
|
2015-04-29 |
2020-01-07 |
Hao Wu |
Jak inhibitors
|
EP3303348B1
(en)
|
2015-05-28 |
2019-08-07 |
Theravance Biopharma R&D IP, LLC |
Naphthyridine compounds as jak kinase inhibitors
|
PT3305788T
(pt)
|
2015-05-29 |
2020-09-25 |
Wuxi Fortune Pharmaceutical Co Ltd |
Inibidor da janus cinase
|
KR20180021740A
(ko)
|
2015-06-02 |
2018-03-05 |
파마싸이클릭스 엘엘씨 |
브루톤 티로신 키나제의 억제제
|
EA039006B1
(ru)
|
2015-06-03 |
2021-11-19 |
Принсипиа Биофарма Инк. |
Ингибиторы тирозинкиназы
|
WO2016192074A1
(en)
|
2015-06-04 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
US20180305350A1
(en)
|
2015-06-24 |
2018-10-25 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
WO2017006953A1
(ja)
|
2015-07-07 |
2017-01-12 |
塩野義製薬株式会社 |
TrkA阻害活性を有する複素環誘導体
|
CA2991020A1
(en)
|
2015-07-07 |
2017-01-12 |
Japan Tobacco Inc. |
Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
|
CN108137559B
(zh)
|
2015-07-09 |
2021-11-02 |
默克专利有限公司 |
用作btk抑制剂的嘧啶衍生物及其用途
|
EP3323817B1
(en)
|
2015-07-16 |
2022-10-19 |
Chia Tai Tianqing Pharmaceutical Group Co.,Ltd |
Aniline pyrimidine derivatives and uses thereof
|
EA035049B1
(ru)
|
2015-07-16 |
2020-04-22 |
Аррэй Байофарма Инк. |
СОЕДИНЕНИЯ ЗАМЕЩЕННОГО ПИРАЗОЛО[1,5-a]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ RET КИНАЗЫ
|
US10550112B2
(en)
|
2015-07-20 |
2020-02-04 |
Dana-Farber Cancer Institute, Inc. |
Pyrimidines as EGFR inhibitors and methods of treating disorders
|
WO2017013237A1
(en)
*
|
2015-07-23 |
2017-01-26 |
Institut Curie |
Use of a combination of dbait molecule and parp inhibitors to treat cancer
|
WO2017016463A1
(zh)
|
2015-07-24 |
2017-02-02 |
上海海雁医药科技有限公司 |
Egfr抑制剂及其药学上可接受的盐和多晶型物及其应用
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
CN106467541B
(zh)
|
2015-08-18 |
2019-04-05 |
暨南大学 |
取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用
|
US10214515B2
(en)
|
2015-08-20 |
2019-02-26 |
Zhejiang Hisun Pharmaceutical Co., Ltd. |
Substituted pyrazoles as inhibitors of fibroblast growth factor receptor
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
EA201890730A1
(ru)
|
2015-09-16 |
2018-10-31 |
Локсо Онколоджи, Инк. |
Производные пиразолопиримидина в качестве ингибиторов btk для лечения злокачественного новообразования
|
EP3144307A1
(en)
|
2015-09-18 |
2017-03-22 |
AB Science |
Novel oxazole derivatives that inhibit syk
|
CN106554347B
(zh)
|
2015-09-25 |
2020-10-30 |
浙江博生医药有限公司 |
Egfr激酶抑制剂及其制备方法和应用
|
WO2017059280A1
(en)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Novel pan-tam inhibitors and mer/axl dual inhibitors
|
CA3008653A1
(en)
|
2015-10-14 |
2017-04-20 |
Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
EP3365335B1
(en)
|
2015-10-23 |
2024-02-14 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases
|
CN108349972B
(zh)
|
2015-11-03 |
2021-06-08 |
施万生物制药研发Ip有限责任公司 |
用于治疗呼吸疾病的jak激酶抑制剂化合物
|
CN106699743B
(zh)
|
2015-11-05 |
2020-06-12 |
湖北生物医药产业技术研究院有限公司 |
嘧啶类衍生物及其用途
|
EP3865485A1
(en)
|
2015-11-06 |
2021-08-18 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of bruton's tyrosine kinase
|
JP2019500328A
(ja)
|
2015-11-19 |
2019-01-10 |
ブループリント メディシンズ コーポレイション |
Ntrkに関連する障害の治療のために有用な化合物及び組成物
|
PL3380486T3
(pl)
|
2015-11-24 |
2020-07-27 |
Theravance Biopharma R&D Ip, Llc |
Proleki związku będącego inhibitorem jak do leczenia choroby zapalnej układu żołądkowo-jelitowego
|
US10159662B2
(en)
|
2015-12-11 |
2018-12-25 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Azetidine derivative, preparation method therefor, and use thereof
|
DK3390390T3
(da)
|
2015-12-16 |
2021-12-06 |
Boehringer Ingelheim Int |
Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
|
CN106928231B
(zh)
|
2015-12-31 |
2021-06-01 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的egfr野生型和突变型的激酶抑制剂
|
AU2017204973A1
(en)
|
2016-01-06 |
2018-07-12 |
Trillium Therapeutics Inc. |
Novel fluorinated quinazoline derivatives as EGFR inhibitors
|
WO2017121444A1
(en)
|
2016-01-11 |
2017-07-20 |
Merck Patent Gmbh |
Quinolin-2-one derivatives
|
WO2017123695A1
(en)
|
2016-01-13 |
2017-07-20 |
Boehringer Ingelheim International Gmbh |
Isoquinolones as btk inhibitors
|
US10662187B2
(en)
|
2016-01-21 |
2020-05-26 |
Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
US10822339B2
(en)
|
2016-01-26 |
2020-11-03 |
Hangzhou Huadong Medicine Group Biopharmaceutical Co. Ltd |
Pyrrolopyrimidine five-membered azacyclic derivative and application thereof
|
CN107021963A
(zh)
|
2016-01-29 |
2017-08-08 |
北京诺诚健华医药科技有限公司 |
吡唑稠环类衍生物、其制备方法及其在治疗癌症、炎症和免疫性疾病上的应用
|
EP3412663B1
(en)
|
2016-02-04 |
2022-09-07 |
Shionogi & Co., Ltd. |
Nitrogen-containing heterocycle and carbocycle derivatives having trka inhibitory activity
|
RU2744432C2
(ru)
|
2016-02-19 |
2021-03-09 |
Цзянсу Хэнжуй Медицин Ко., Лтд. |
Фармацевтическая композиция, включающая ингибитор янус-киназы или его фармацевтически приемлемую соль
|
AU2017222908B2
(en)
|
2016-02-23 |
2021-02-04 |
Taiho Pharmaceutical Co., Ltd. |
Novel condensed pyrimidine compound or salt thereof
|
CN109069528B
(zh)
*
|
2016-03-01 |
2021-11-05 |
欧恩科斯欧公司 |
DBait分子在制备用于治疗三阴性乳腺癌的药物中的用途
|
CN107151249B
(zh)
|
2016-03-04 |
2020-08-14 |
华东理工大学 |
作为flt3抑制剂的蝶啶酮衍生物及应用
|
WO2017161269A1
(en)
|
2016-03-17 |
2017-09-21 |
Blueprint Medicines Corporation |
Inhibitors of ret receptor tyrosine kinases
|
CN107286077B
(zh)
|
2016-04-01 |
2021-04-02 |
合肥中科普瑞昇生物医药科技有限公司 |
一种选择性的c-kit激酶抑制剂
|
CN109562181A
(zh)
|
2016-04-29 |
2019-04-02 |
X-化学有限公司 |
共价btk抑制剂及其用途
|
SG11201809751XA
(en)
|
2016-05-26 |
2018-12-28 |
Zeno Royalties & Milestones Llc |
Egfr inhibitor compounds
|
CN107759600A
(zh)
|
2016-06-16 |
2018-03-06 |
正大天晴药业集团股份有限公司 |
作为jak抑制剂的吡咯并嘧啶化合物的结晶
|
EP3476848A4
(en)
|
2016-06-27 |
2020-01-15 |
Hangzhou Rex Pharmaceutical Co., Ltd |
BENZOFURANE-PYRAZOLE-AMINE PROTEIN KINASE INHIBITOR
|
WO2018002958A1
(en)
|
2016-06-30 |
2018-01-04 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazide containing compounds as btk inhibitors
|
KR102215172B1
(ko)
|
2016-06-30 |
2021-02-16 |
항저우 방순 파마슈티컬 컴퍼니, 리미티드 |
이미다조피라진아민 페닐 유도체 및 그의 용도
|
US10399988B2
(en)
|
2016-07-07 |
2019-09-03 |
Daewoong Pharmaceutical Co., Ltd. |
4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
US10035789B2
(en)
|
2016-07-27 |
2018-07-31 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
CN107698593A
(zh)
|
2016-08-09 |
2018-02-16 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
JP6954994B2
(ja)
|
2016-08-16 |
2021-10-27 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
可逆性btk阻害剤としてのオキソ−イミダゾピリジン及びその使用
|
AU2017319135B2
(en)
|
2016-08-29 |
2021-03-18 |
The Regents Of The University Of Michigan |
Aminopyrimidines as ALK inhibitors
|
TW201822764A
(zh)
|
2016-09-14 |
2018-07-01 |
美商基利科學股份有限公司 |
Syk抑制劑
|
WO2018053190A1
(en)
|
2016-09-14 |
2018-03-22 |
Gilead Sciences, Inc. |
Syk inhibitors
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
CN107840846B
(zh)
|
2016-09-19 |
2020-11-24 |
郑州泰基鸿诺医药股份有限公司 |
一种含嘧啶环的化合物、egfr抑制剂及其应用
|
JP2018052878A
(ja)
|
2016-09-29 |
2018-04-05 |
第一三共株式会社 |
ピリジン化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
WO2018079759A1
(ja)
|
2016-10-31 |
2018-05-03 |
塩野義製薬株式会社 |
TrkA阻害活性を有する縮合複素環および縮合炭素環誘導体
|
KR20180051220A
(ko)
|
2016-11-08 |
2018-05-16 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
CN108069974B
(zh)
|
2016-11-15 |
2019-12-10 |
杭州和正医药有限公司 |
一种选择性布鲁顿酪氨酸激酶抑制剂及其应用
|
JP2020500194A
(ja)
|
2016-11-18 |
2020-01-09 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Alk阻害物質としての5,6−ジヒドロ−11h−インドロ[2,3−b]キノリン−11−オン
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
WO2018108083A1
(zh)
|
2016-12-12 |
2018-06-21 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
WO2018108064A1
(zh)
|
2016-12-13 |
2018-06-21 |
南京明德新药研发股份有限公司 |
作为第四代egfr激酶抑制剂的螺环芳基磷氧化合物
|
CN117050032A
(zh)
|
2016-12-15 |
2023-11-14 |
阿瑞雅德制药公司 |
作为c-kit抑制剂的氨基噻唑化合物
|
WO2018112140A1
(en)
|
2016-12-15 |
2018-06-21 |
Ariad Pharmaceuticals, Inc. |
Benzimidazole compounds as c-kit inhibitors
|
CN108250200A
(zh)
|
2016-12-28 |
2018-07-06 |
中国科学院上海药物研究所 |
一种具有Axl抑制活性的化合物及其制备和应用
|
US11130761B2
(en)
|
2016-12-29 |
2021-09-28 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors
|
US11040984B2
(en)
|
2016-12-30 |
2021-06-22 |
Medshine Discovery Inc. |
Quinazoline compound for EGFR inhibition
|
CN108276410B
(zh)
|
2017-01-06 |
2021-12-10 |
首药控股(北京)股份有限公司 |
一种间变性淋巴瘤激酶抑制剂及其制备方法和用途
|
JP6899504B2
(ja)
|
2017-01-10 |
2021-07-07 |
ゼジアン ジャーチ デベロップメント ファーマシューティカルズ リミテッド |
膜開始エストロゲンシグナルのラソフォキシフェンでのモジュレーションおよび腫瘍の治療方法
|
WO2018136663A1
(en)
|
2017-01-18 |
2018-07-26 |
Array Biopharma, Inc. |
Ret inhibitors
|
US11168090B2
(en)
|
2017-01-18 |
2021-11-09 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
|
CN106831787B
(zh)
|
2017-01-20 |
2018-10-23 |
成都倍特药业有限公司 |
用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用
|
JP7164203B2
(ja)
|
2017-02-08 |
2022-11-01 |
中国医▲薬▼研究▲開▼▲発▼中心有限公司 |
ピロロ芳香族複素環化合物及びその製造方法並びに医薬用途
|
EP3587419A4
(en)
|
2017-02-27 |
2020-08-05 |
Betta Pharmaceuticals Co., Ltd. |
FGFR INHIBITOR AND APPLICATION OF IT
|
US10464923B2
(en)
|
2017-02-27 |
2019-11-05 |
Merck Patent Gmbh |
Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone
|
WO2018153293A1
(zh)
|
2017-02-27 |
2018-08-30 |
北京赛特明强医药科技有限公司 |
二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
WO2018175512A1
(en)
|
2017-03-22 |
2018-09-27 |
Suzhou Baijibugong Pharmaceutical Technology Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
WO2018187355A1
(en)
|
2017-04-03 |
2018-10-11 |
Health Research Inc. |
Met kinase inhibitors and uses therefor
|
CN108721298A
(zh)
|
2017-04-19 |
2018-11-02 |
华东理工大学 |
作为布鲁顿酪氨酸激酶抑制剂的嘧啶并杂环化合物及其应用
|
CN108727382B
(zh)
|
2017-04-19 |
2022-07-19 |
华东理工大学 |
作为btk抑制剂的杂环化合物及其应用
|
CN107043366B
(zh)
|
2017-04-25 |
2020-05-26 |
中国药科大学 |
4-氨基嘧啶类化合物、其制备方法及医药用途
|
AU2018257203B2
(en)
|
2017-04-27 |
2022-05-26 |
Mochida Pharmaceutical Co., Ltd. |
Novel tetrahydronaphthyl urea derivatives
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
WO2018208132A1
(en)
|
2017-05-12 |
2018-11-15 |
Korea Research Institute Of Chemical Technology |
Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient
|
EP3630766A1
(en)
|
2017-05-22 |
2020-04-08 |
H. Hoffnabb-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
WO2018215390A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
CN107176954B
(zh)
|
2017-06-02 |
2019-01-11 |
无锡双良生物科技有限公司 |
一种egfr抑制剂的药用盐及其晶型、制备方法和应用
|
CA3065114A1
(en)
|
2017-06-14 |
2018-12-20 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Syk inhibitor and use method therefor
|
CN109111446B
(zh)
|
2017-06-22 |
2021-11-30 |
上海度德医药科技有限公司 |
一种具有药物活性的杂芳基化合物
|
KR20200020888A
(ko)
|
2017-06-27 |
2020-02-26 |
얀센 파마슈티카 엔.브이. |
신규 퀴놀리논 화합물
|
JP2020526499A
(ja)
|
2017-07-05 |
2020-08-31 |
シーエス ファーマテック リミテッド |
Egfrチロシンキナーゼの臨床上重要な突然変異体の選択的阻害剤
|
CN110997677A
(zh)
|
2017-08-12 |
2020-04-10 |
百济神州有限公司 |
具有改进的双重选择性的Btk抑制剂
|
US11236094B2
(en)
|
2017-08-15 |
2022-02-01 |
Cspc Zhongqi Pharmaceuticall Technology (Shijiazhuang) Co., Ltd. |
Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors
|
WO2019034075A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr和egfr抑制剂
|
US11384076B2
(en)
|
2017-08-18 |
2022-07-12 |
Universität Regensburg |
Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors
|
CN109400610A
(zh)
|
2017-08-18 |
2019-03-01 |
浙江海正药业股份有限公司 |
吡咯并三嗪类衍生物、其制备方法及其在医药上的用途
|
US20200172529A1
(en)
|
2017-08-18 |
2020-06-04 |
Beijing Hanmi Pharm. Co., Ltd. |
Chemical Compound, Pharmaceutical Composition Thereof, and Use and Application Thereof
|